8-K: FOXO Technologies Completes 1-for-3,000 Reverse Stock Split

FOXO Technologies Inc. announced the effectiveness of its 1-for-3,000 reverse stock split, aimed at increasing its per-share stock price for potential OTCQB quotation and future exchange uplisting.

Summary

• FOXO Technologies Inc. has completed a 1-for-3,000 reverse stock split, which became effective on June 30, 2026.
• This action consolidates every 3,000 shares of Class A Common Stock into one share.
• The reverse stock split is intended to increase the per-share stock price to meet the minimum requirements for quotation on OTCQB ($0.01 or higher) and as a step towards a potential uplisting to a recognized exchange.
• The company's common stock began trading on a split-adjusted basis on July 1, 2026, under the temporary symbol FOXOD, with a new CUSIP number (351471602).
• The trading symbol is expected to revert to FOXO on or about July 20, 2026.
• No fractional shares will be issued; any fractional shares resulting from the split will be rounded up to the nearest whole share.
• All outstanding stock options, warrants, and equity incentive plans will be proportionately adjusted.
• The company believes this move is in the best interest of the company and its stockholders, aiming to generate greater interest from professional investors and institutions, leading to increased liquidity and a stronger investor base.
• FOXO Technologies owns four subsidiaries: Rennova Community Health, Inc. (operating a hospital), Myrtle Recovery Centers, Inc. (behavioral health facility), Vector BioSource, Inc. (data and biospecimen sourcing), and FOXO Labs, Inc. (biotechnology).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral to slightly positive development. While the reverse split itself doesn't change the company's intrinsic value, it's a necessary step to improve marketability and potentially attract investment, which is a positive strategic move.

Positives

• The reverse stock split is expected to increase the per-share stock price, potentially enabling quotation on OTCQB and facilitating a future uplisting to a major exchange.
• The company anticipates that a higher stock price will attract greater interest from professional investors and institutions, potentially leading to increased liquidity and a stronger investor base.
• The reverse stock split is designed to align with listing requirements for exchanges, which could improve the company's market standing.
• No fractional shares will be issued, and any resulting fractional shares will be rounded up, ensuring no stockholders are disadvantaged by fractional share payouts.

Negatives

• The reverse stock split does not change the fundamental value of the company or its business operations.
• The company has a history of losses and may not achieve or maintain profitability in the future, as noted in the forward-looking statements.
• The company's stock is currently trading on OTC, indicating a lower market tier compared to major exchanges.

Risks

• The risk of changes in the competitive and highly regulated industries in which FOXO operates.
• Variations in operating performance across competitors or changes in laws and regulations affecting FOXO's business.
• The ability to implement FOXO's business plans, forecasts, and other expectations.
• The ability to obtain necessary financing.
• The risk that FOXO has a history of losses and may not achieve or maintain profitability in the future.
• The enforceability of FOXO's intellectual property, including its patents, and the potential infringement on the intellectual property rights of others.
• The risk of downturns and a changing regulatory landscape in the highly competitive industries in which FOXO operates.

Future Outlook

The company anticipates that the reverse stock split will increase its per-share stock price, making it eligible for OTCQB quotation and potentially facilitating a future uplisting to a recognized exchange. The company may explore additional financing opportunities or strategic transactions that would require the issuance of additional shares of Common Stock, but no such plans are currently pending. The company does not expect the reverse stock split to impact its current or future business operations.

Management Comments

• "We believe that if we are successful in maintaining a higher stock price, the stock will generate greater interest among professional investors and institutions."
• "If we are successful in generating interest from such entities, we anticipate that our Common Stock would have greater liquidity and a stronger investor base."
• "Accordingly, for these and other reasons, we believe that effecting the Reverse Split is in the Companys and our stockholders best interests."
• "The Company does not expect the Reverse Split to impact its current or future business operations."

Industry Context

StockSavvy.ai notes that reverse stock splits are a common tactic for companies seeking to improve their stock's market perception and meet exchange listing requirements, particularly for those trading on over-the-counter markets. This move by FOXO Technologies aligns with industry practices aimed at attracting institutional investors and potentially facilitating access to capital markets.

Corporate Governance

Stakeholder Impact

• Shareholders will hold fewer shares, but each share will represent a proportionally larger ownership stake, with no change in their overall percentage of ownership, except for fractional share adjustments.
• The reverse stock split aims to increase interest from professional investors and institutions, potentially benefiting the investor base.
• The company's business operations are not expected to be impacted.

Next Steps

• Common stock will trade under the temporary symbol FOXOD until approximately July 20, 2026.
• The trading symbol is expected to revert to FOXO on or about July 20, 2026.
• The company may explore additional financing opportunities or strategic transactions.

Key Dates

Recommendation

The reverse stock split is a procedural change aimed at improving market perception and meeting listing requirements, rather than a fundamental business development. While it may attract more investor interest, it does not inherently change the company's financial performance or future prospects. Therefore, a 'hold' recommendation is appropriate pending further operational or financial updates.

Keywords

reverse stock split, FOXO Technologies, OTC, stock price, uplisting, common stock, Delaware, Rennova Community Health, Myrtle Recovery Centers, Vector BioSource, FOXO Labs, biotechnology, healthcare